The Genome Engineering and Stem Cell Center (GESC) Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by The Genome Engineering and Stem Cell Center (GESC) and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 2 The Genome Engineering and Stem Cell Center (GESC) employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that The Genome Engineering and Stem Cell Center (GESC) has purchased the following applications: Amazon EC2 for Application Hosting and Computing Services in 2025, L7 LIMS for Laboratory Management in 2021, Heap Analytics for Marketing Analytics in 2025 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems The Genome Engineering and Stem Cell Center (GESC) is running and its propensity to invest more and deepen its relationship with Amazon Web Services (AWS) , L7 Informatics , Heap or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing The Genome Engineering and Stem Cell Center (GESC) revenues, which have grown to $2.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for The Genome Engineering and Stem Cell Center (GESC) intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.